Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001326389-25-000109·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON Biopharma, Inc.
Class A ordinary shares, par value $0.0001 per share · CUSIP: 00791X100
Event date: 2024-12-31
- Filing-level shares
- 2,762,688
- Percent of class
- 6.9%
- Polar Asset Management Partners Inc.
Shares: 2,762,688 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001326389-25-000109
- Form type
- SCHEDULE 13G/A
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership